Number of Shares
2.48 Mil
Current Holdings Value*
kr224.39 Mil
% of Portfolio
1.28%
Total Estimate Gain
kr444.79 Mil
% of Total Estimate Gain
16.87%

MFS International Growth Fund's Novo Nordisk AS Holding Summary

As of 2025-02-28, MFS SERIES TRUST X held 2.48 Mil shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr224.39 Mil. This investment constitutes 1.28% of their stock portfolio, and MFS SERIES TRUST X now holds 0.06% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then MFS International Growth Fund has made 6 purchases of OCSE:NOVO B, at an average price of kr336.54, for a total of 7.83 Mil shares. In addition, there have been 5 sales at an average price of kr379.19 for 5.36 Mil shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, MFS International Growth Fund's estimated gain on his OCSE:NOVO B holdings is kr444.79 Mil, reflecting a 16.87% gain to date.

MFS International Growth Fund OCSE:NOVO B (kr423.90) Holding Chart

MFS International Growth Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1